TickerFactsScreenerDevelopers

SELLAS Life Sciences Group, Inc. (SLS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$12.49M2012: -$21.20M2013: -$28.49M2014: -$43.90M2015: -$34.22M2016: -$15.99M2017: -$23.04M2019: -$20.04M2020: -$16.98M2021: -$25.29M2022: -$41.95M2023: -$37.87M2024: -$31.51M2025: -$28.27M-$28.27M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$28.27M+10.3%
2024-$31.51M+16.8%
2023-$37.87M+9.7%
2022-$41.95M-65.8%
2021-$25.29M-48.9%
2020-$16.98M+15.3%
2019-$20.04M—
2017-$23.04M-44.1%
2016-$15.99M+53.3%
2015-$34.22M+22.1%
2014-$43.90M-54.1%
2013-$28.49M-34.4%
2012-$21.20M-69.8%
2011-$12.49M—